Browse all Peptides & GLP-1 education Editorial note: This independent article is educational
Choose NAC if your main focus is antioxidant defense, glutathione support, liver support, or respiratory support
That variability comes down to receptor sensitivity and baseline gastric tolerance
The image below highlights the mechanisms of both GLP-1 and GIP, along with a callout to the newest treatment optiona triple incretin that also includes glucagonexpected to be approved in late 2025 to early 2026
To our knowledge, no retrospective studies have been conducted to assess the effectiveness of semaglutide at the doses used to treat obesity (ie, 1.7 and 2.4 mg). Researchers conducted a cohort study at a referral center for weight management and included 175 patients (mean age, 49.3 years
Biomarkers including fasting glucose, HbA1c, liver enzyme panels, and inflammatory markers can help contextualize whether dose escalation aligns with your physiological response